“Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.” Myriam Delaunay, Jacques Cadranel, Amélie Lusque, Nicolas Meyer, Valérie Gounant, Denis Moro-Sibilot, Jean-Marie Michot, Judith Raimbourg, Nicolas Girard, Florian Guisier, David Planchard, Anne-Cécile Metivier, Pascale Tomasini, Eric Dansin, Maurice Pérol, Marion Campana, Oliver Gautschi, Martin Früh, Jean-David Fumet, Clarisse Audigier-Valette, Sébastien Couraud, Stéphane Dalle, Marie-Thérèse Leccia, Marion Jaffro, Samia Collot, Grégoire Prévot, Julie Milia and Julien Mazieres. Eur Respir J 2017; 50: 1700050.

European Respiratory Journal 2017 50: 1750050; DOI: 10.1183/13993003.50050-2017

This article from the August 2017 issue of the European Respiratory Journal was published with an error in one of the author names (Valérie Gounant). The article has been corrected and republished online.

View Abstract
Back to top
View this article with LENS
Email
Print
Alerts
Citation Tools

“Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.” Myriam Delaunay, Jacques Cadranel, Amélie Lusque, Nicolas Meyer, Valérie Gounant, Denis Moro-Sibilot, Jean-Marie Michot, Judith Raimbourg, Nicolas Girard, Florian Guisier, David Planchard, Anne-Cécile Metivier, Pascale Tomasini, Eric Dansin, Maurice Pérol, Marion Campana, Oliver Gautschi, Martin Früh, Jean-David Fumet, Clarisse Audigier-Valette, Sébastien Couraud, Stéphane Dalle, Marie-Thérèse Leccia, Marion Jaffro, Samia Collot, Grégoire Prévot, Julie Milia and Julien Mazieres. Eur Respir J 2017; 50: 1700050.
European Respiratory Journal Nov 2017, 50 (5) 1750050; DOI: 10.1183/13993003.50050-2017
Digg logo Reddit logo Technorati logo Twitter logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To